This is an area where there is a lot of collaboration between the players within Canada, and this is to do with the development of technetium 99 as a radioisotope for medical imaging. There are several players. The Canadian Light Source has an approach. TRIUMF is heavily engaged in the production of these isotopes, as well, so we developed a new process to allow us to create those isotopes.
We work with Chalk River. We work with CNL. That's part of that collaborative aspect of ensuring that we're working across the major research facilities generally, but this is an area that is growing, and TRIUMF is aiming to be one of the—